Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) — Cash Flow-to-Debt Ratio
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥127.35 Million could theoretically repay 0% of its total liabilities (CN¥2.10 Billion) in one year. See Beijing Wantai Biological Pharmacy Enter free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Beijing Wantai Biological Pharmacy Enterprise Co Ltd across 13 annual periods. Also explore Beijing Wantai Biological Pharmacy Enter (603392) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)
Year-by-year debt coverage analysis for Beijing Wantai Biological Pharmacy Enterprise Co Ltd. For market capitalisation and broader financial context, see Beijing Wantai Biological Pharmacy Enter market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥89.75 Million | CN¥2.01 Billion | ▼ -71.8% |
| 2024 | 0.16x | CN¥355.08 Million | CN¥2.24 Billion | ▼ -72.0% |
| 2023 | 0.57x | CN¥1.60 Billion | CN¥2.83 Billion | ▼ -49.8% |
| 2022 | 1.13x | CN¥4.13 Billion | CN¥3.66 Billion | ▲ +66.5% |
| 2021 | 0.68x | CN¥1.68 Billion | CN¥2.48 Billion | ▲ +33.6% |
| 2020 | 0.51x | CN¥468.21 Million | CN¥923.29 Million | ▲ +8.6% |
| 2019 | 0.47x | CN¥272.68 Million | CN¥584.19 Million | ▼ -0.5% |
| 2018 | 0.47x | CN¥208.31 Million | CN¥444.24 Million | ▲ +141.5% |
| 2017 | 0.19x | CN¥146.97 Million | CN¥756.80 Million | ▼ -25.7% |
| 2016 | 0.26x | CN¥129.40 Million | CN¥494.76 Million | ▼ -34.7% |
| 2015 | 0.40x | CN¥151.84 Million | CN¥378.93 Million | ▼ -31.9% |
| 2014 | 0.59x | CN¥132.43 Million | CN¥225.19 Million | ▲ +35.2% |
| 2013 | 0.43x | CN¥97.83 Million | CN¥224.92 Million | — |